@ShahidNShah
This rapid systematic review and horizon scan aimed to identify technologies available or in development to support the monitoring and self-management of asthma and/or chronic obstructive pulmonary disease (COPD) outside traditional healthcare settings in England.
Literature searches targeted systematic reviews from 2020 to 2023 and employed complementary horizon scanning methods to gather data on identified technologies and potentially discover new ones. The Grading of Recommendations, Assessment, Development and Evaluations framework assessed the certainty of evidence for each technology. Sources included medical databases, trial registries, company websites and app stores. Eligible technologies were those used for asthma or COPD, designed for out-of-clinic use, capable of self-monitoring or early exacerbation identification, portable and using artificial intelligence or remote monitoring features.
Emerging digital and sensor-enabled tools—such as smart inhalers and connected monitoring systems—are showing promise for improving adherence, tracking symptoms, and supporting personalized asthma and COPD care outside clinical settings, which is especially relevant for managing chronic respiratory disease in U.S. community and home environments.
Continue reading at innovations.bmj.com
The healthcare landscape is in constant flux. From cyber threats and financial pressures to rapidly evolving technologies, leaders face unprecedented challenges. But navigating these disruptions …
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2025 Netspective Foundation, Inc. All Rights Reserved.
Built on Dec 23, 2025 at 12:14pm